Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study

Eva Segelov, Subotheni Thavaneswaran, Paul Waring, Jayesh Desai, Kristy Robledo, Val Gebski, Elena Elez, Louise Nott, Christos Karapetis, Sebastian Lunke, Lorraine Chantrill, Nick Pavlakis, Mustafa Khasraw, Craig Underhill, Fortunato Ciardiello, Michael Jefford, Harpreet Hawan, Andrew Haydon, Timothy Price, Guy van HazelKate Wilson, John Simes, Jeremy Shapiro

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study'. Together they form a unique fingerprint.

    Medicine & Life Sciences